Ferrer, Juniza E.
HRN: 09-56-20 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/05/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/05/2022
08/12/2022
IV
675mg
Q6hours
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes